医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mitsui Chemicals Commences Operations at Korean Subsidiary

2016年03月15日 PM01:30
このエントリーをはてなブックマークに追加


 

TOKYO

Mitsui Chemicals, Inc. (TOKYO:4183) (President & CEO: Tsutomu Tannowa) announced that it will commence operations at its new Korean subsidiary, Mitsui Chemicals Korea, Inc., on April 1, 2016. The new company is a restructuring of the Mitsui Chemicals, Inc. Korean Branch which was established on October 1, 2014.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160314005497/en/

Photo of Mitsui Chemicals Korea, Inc. (Photo: Business Wire)

Photo of Mitsui Chemicals Korea, Inc. (Photo: Business Wire)

The new company will form an optimum sales network to further expand Mitsui Chemicals operations in Korea mainly targeting materials for automotive and electrical/electronic products.

 

Outline of Mitsui Chemicals Korea, Inc.

Company name   Mitsui Chemicals Korea, Inc.
Capital 1 billion wong(approx. 100 million yen)
Location Yongsan Building 9th floor, 273 Hangang-daero, Yongsan-gu, Seoul, Korea
President Hiroyuki Furukawa
Telephone number   +82-2-702-3134
 

Background
Korea is an important market with world class automobile and electrical/electronic manufacturers. For the Mitsui Chemicals Group, which lists the mobility segment as one of three priority targets, Korea is extremely attractive with good potentials for business growth and expansion. In addition, the Korean market also holds equally good potential for the Group’s other two priority business areas of healthcare and food & packaging.

Mitsui Chemicals Korean branch was established in October 2014 to collect information on the Korean market and provide cutting edge service to customers with an eye on a future status upgrade to that of a local subsidiary with sales functions to further bolster the Company’s business interest in the country. Mitsui Chemicals will continue to strengthen its business development in Korea while fulfilling its role as a good corporate citizen.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160314005497/en/

CONTACT

Mitsui Chemicals, Inc.
Takashi Kawamoto, +81-3-6253-2100
Corporate
Communications Div.
takashi.kawamoto@mitsuichemicals.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Dompé用于治疗中度或重度神经营养性角膜炎成人患者的Oxervate®(Cenegermin滴眼液)获得欧盟CHMP肯定意见
  • SCIEX Sponsored Award Recognizes Notable Contributions to Electrodriven Separations
  • LMDのV-Sensorがインドでバイタルサインを測定
  • オクタファルマ、薬物動態に基づくNuwiq®個別化予防療法(NuPreviq法)に関する新しい臨床データの発表により、血友病A患者への強いコミットメントを浮き彫りに
  • ハーバライフ・ニュートリション、健康的でアクティブな生活を促すリーダーとなれるよう、東南アジアのメンバーを鼓舞